NEXEN TIRE Announces Executive Appointments
-- Company to Promote Next-Generation Leaders in Key Business Areas Including Sales, Production, and R&D --
The newly promoted CEO
Since 2016, CEO
Since 2021, he has served as the Head of the Global OE (Original Equipment) Sales Business Group, overseeing OE supply and leading the expansion of premium OE supply. Currently, NEXEN TIRE supplies products to 28 automotive manufacturers for 118 vehicle models, successfully increasing brand recognition.
Through these executive appointments, NEXEN TIRE plans to further solidify its worldwide competitiveness, and respond quickly to the rapidly changing market environment, as well as signal a generational shift towards the future.
"As this leadership restructuring will provide NEXEN TIRE with an opportunity to take a significant leap forward," said
Executive Appointments at Nexen Tire
CEO Promotion
- John Bosco (Hyeon Suk)
Kim
Business Group (BG) Head Promotions
DAE CHOONG KIM , Global Sales BG Leader- CHULJUN KIM, Global Production BG Leader
- JONGMYOUNG KIM, Head of Central Research Institute
- BONHYONG GOO, Head of Management Administration
For more information or to set up an interview with a NEXEN TIRE representative, please contact [email protected] or call (615) 463-3050.
About NEXEN TIRE
NEXEN TIRE, established in 1942, is a global tire manufacturer headquartered in
For more information, please visit http://www.nexentire.com/international/
Nexen Public Relations
Nexen Tire America
(615) 463-3050
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/nexen-tire-announces-executive-appointments-302320749.html
SOURCE Nexen Tire America
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Study Reveals How Lung Tumors "Hack" into Nervous System to Starve the Body
- San Diego Zoo Wildlife Alliance Welcomes Two New Executives to Its Leadership Team
- Blue Earth Therapeutics announces first participant dosed in Phase 1 clinical trial investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in metastatic castration-resistant prostate cancer
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share